The Future of Drug Discovery : Who Decides Which Diseases to Treat?
This thought-provoking book is the first to: provide an in-depth, broad perspective on the crisis in drug industry; expose the disconnect between what society needs and what the drug companies are working on; analyse and project over 10 years into the future; explain what it means for scientists and society; and determine what is needed to be done to make sure that the industry responds to society's needs, remains commercially attractive and answers the question as to who decides which diseases to treat.
- Paperback | 376 pages
- 152 x 229 x 23mm | 590g
- 01 Aug 2013
- Elsevier Science Publishing Co Inc
- Academic Press Inc
- San Diego, United States
- Illustrated; Illustrations, unspecified
Other books in this series
08 Jul 2015
01 Aug 2015
29 Sep 2015
16 Oct 2009
13 Apr 2015
01 Jan 2014
16 Nov 2011
01 Aug 2011
13 Dec 2013
Table of contents
01 - Why there will be new drugs despite the ongoing 'crisis' of drug development in big pharma
02 - The need for medicine grows
03 - Medicines are becoming better
04 - Which diseases do we want to treat?
05 - Therapeutic Areas: strategically important diseases for the future
06 - Blockbuster proprietary drugs versus generic drugs
07 - Why is pharma a special industry?
08 - Diagnosing towards personalized medicine
09 - Personalized medicine
10 - How much can drugs cost?
11 - Modeling Drug Discovery until 2025
12 - Drug development models between 2010 and 2025
"Bartfai and Lees describe the looming crisis in health care.They target society in general as their audience, because of the need for the public to understand what is happening and why they should be concerned. The book is a compendium of data and analysis and there are many tables and figures supporting the text." --Reference and Research Book News, August 2013
"A remarkable compendium of hard data and wise prescription for the pharmaceutical industry." --Michael S. Brown, 1985 Novel Laureate in Medicine or Physiology, UT Southwestern Medical Center
"This is an extraordinary, insightful and provocative book that should be read by all those concerned by the progress of biomedicine, from scientists to politicians." --Jean-Pierre Changeux, Collège de France and l'Institut Pasteur
"Bartfai and Lees raise critical issues confronting the search for new medicines. Their analysis is cogent, and their proposals thoughtful and thought provoking. For anyone curious about where new medicines come from, and what it will take for the BioPharma industry to bring new treatments to patients with Alzheimer's disease, diabetes, depression, cancer, and more, this is a must read." --Michael D. Ehlers, Senior VP Pfizer and CSO Neuroscience, former Howard Hughes Investigator, Duke University
"This book is a must read for students, prescribing physicians, academic and industry researchers, analysts, patient groups, business and science journalists, and importantly, Policy Makers. More than ever before, drug development is a complex scientific, industrial and societal endeavour that needs the combined attention of Governments, Academics and Big Pharma; it cannot be left to Wall Street alone." --Daniel Hoyer, Chair, Department of Pharmacology, University of Melbourne, former Novartis Leading Scientist
About Dr. Graham V. Lees